Review



the pd-l1 negative control cell line  (IncellDx Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    IncellDx Inc the pd-l1 negative control cell line
    Workflow for CTC capture and <t>PD-L1</t> analysis
    The Pd L1 Negative Control Cell Line, supplied by IncellDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/the+pd-l1+negative+control+cell+line/the+pd+l1+negative+control+cell+line/pmc06584214-139-8-16
    Average 90 stars, based on 1 article reviews
    the pd-l1 negative control cell line - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer"

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

    Journal: Cancer Immunology, Immunotherapy

    doi: 10.1007/s00262-019-02344-6

    Workflow for CTC capture and PD-L1 analysis
    Figure Legend Snippet: Workflow for CTC capture and PD-L1 analysis

    Techniques Used:

    Examples of PD-L1 IHC staining of FFPE sections from NSCLC patients (× 100): a PD-L1(−) negative; b positive control (× 200), c PD-L1(+) positive, < 50% immunoreactive, d PD-L1(+) positive, > 50% immunoreactive
    Figure Legend Snippet: Examples of PD-L1 IHC staining of FFPE sections from NSCLC patients (× 100): a PD-L1(−) negative; b positive control (× 200), c PD-L1(+) positive, < 50% immunoreactive, d PD-L1(+) positive, > 50% immunoreactive

    Techniques Used: Immunohistochemistry, Positive Control

    PD-L1 expression levels in ten cancer cell lines and in PD-L1 positive and negative control cells from the BioINK staining kit
    Figure Legend Snippet: PD-L1 expression levels in ten cancer cell lines and in PD-L1 positive and negative control cells from the BioINK staining kit

    Techniques Used: Expressing, Negative Control, Staining

    Example images of PD-L1 positive and negative staining patterns
    Figure Legend Snippet: Example images of PD-L1 positive and negative staining patterns

    Techniques Used: Negative Staining

    CTC detection rate and PD-L1% in treatment-naïve NSCLC patients
    Figure Legend Snippet: CTC detection rate and PD-L1% in treatment-naïve NSCLC patients

    Techniques Used:

    2 × 2 Confusion matrix and performance measures
    Figure Legend Snippet: 2 × 2 Confusion matrix and performance measures

    Techniques Used:

    Related Articles

    Positive Control:

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer
    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Negative Control:

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer
    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Immunohistochemistry:

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer
    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Expressing:

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer
    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Staining:

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer
    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Negative Staining:

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer
    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).



    Similar Products

    the pd-l1 negative control cell line  (IncellDx Inc)
    90
    IncellDx Inc the pd-l1 negative control cell line
    Workflow for CTC capture and <t>PD-L1</t> analysis
    The Pd L1 Negative Control Cell Line, supplied by IncellDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/the+pd-l1+negative+control+cell+line/the+pd+l1+negative+control+cell+line/pmc06584214-139-8-16
    Average 90 stars, based on 1 article reviews
    the pd-l1 negative control cell line - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Workflow for CTC capture and PD-L1 analysis

    Journal: Cancer Immunology, Immunotherapy

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

    doi: 10.1007/s00262-019-02344-6

    Figure Lengend Snippet: Workflow for CTC capture and PD-L1 analysis

    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Techniques:

    Examples of PD-L1 IHC staining of FFPE sections from NSCLC patients (× 100): a PD-L1(−) negative; b positive control (× 200), c PD-L1(+) positive, < 50% immunoreactive, d PD-L1(+) positive, > 50% immunoreactive

    Journal: Cancer Immunology, Immunotherapy

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

    doi: 10.1007/s00262-019-02344-6

    Figure Lengend Snippet: Examples of PD-L1 IHC staining of FFPE sections from NSCLC patients (× 100): a PD-L1(−) negative; b positive control (× 200), c PD-L1(+) positive, < 50% immunoreactive, d PD-L1(+) positive, > 50% immunoreactive

    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Techniques: Immunohistochemistry, Positive Control

    PD-L1 expression levels in ten cancer cell lines and in PD-L1 positive and negative control cells from the BioINK staining kit

    Journal: Cancer Immunology, Immunotherapy

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

    doi: 10.1007/s00262-019-02344-6

    Figure Lengend Snippet: PD-L1 expression levels in ten cancer cell lines and in PD-L1 positive and negative control cells from the BioINK staining kit

    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Techniques: Expressing, Negative Control, Staining

    Example images of PD-L1 positive and negative staining patterns

    Journal: Cancer Immunology, Immunotherapy

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

    doi: 10.1007/s00262-019-02344-6

    Figure Lengend Snippet: Example images of PD-L1 positive and negative staining patterns

    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Techniques: Negative Staining

    CTC detection rate and PD-L1% in treatment-naïve NSCLC patients

    Journal: Cancer Immunology, Immunotherapy

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

    doi: 10.1007/s00262-019-02344-6

    Figure Lengend Snippet: CTC detection rate and PD-L1% in treatment-naïve NSCLC patients

    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Techniques:

    2 × 2 Confusion matrix and performance measures

    Journal: Cancer Immunology, Immunotherapy

    Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

    doi: 10.1007/s00262-019-02344-6

    Figure Lengend Snippet: 2 × 2 Confusion matrix and performance measures

    Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

    Techniques: